PMI Responds to 'Why is PMI Still Selling Cigarettes': Stopping Sales Is Not the Solution, Driving Consumer Transformation Is Key

Nov.28.2024
PMI Responds to 'Why is PMI Still Selling Cigarettes': Stopping Sales Is Not the Solution, Driving Consumer Transformation Is Key
PMI recently addressed the ongoing controversy regarding its continued sale of cigarettes on LinkedIn, emphasizing that achieving a smoke-free future requires reducing demand for cigarettes rather than an outright ban. The company's Chief Communications Officer said that simply halting cigarette sales will not solve the demand issue but will instead drive the market toward illegal trade or other brands.

Recently, Philip Morris International (PMI) addressed the long-standing question on LinkedIn: "Why is PMI still selling cigarettes?" In its response, PMI emphasized that achieving a smoke-free future requires a gradual reduction in cigarette demand, rather than an immediate ban.

 

The company outlined three key reasons:

 

  • Consumer Behavior Takes Time to Change: PMI's goal is to encourage adults who have not yet quit smoking to switch to smoke-free alternatives. This shift in consumer behavior takes time. The company emphasized that without this change, an outright ban on cigarettes would not solve the issue. Consumers could turn to competing brands or the illegal market, complicating efforts to control smoking.

 

  • Legal Restrictions Limit Product Diversification: In some countries, current laws only allow the sale of traditional tobacco products (such as cigarettes and cigars). These legal constraints hinder PMI's ability to promote smoke-free products, delaying progress toward a smoke-free future.

 

  • Balancing Shareholder Responsibility: As a publicly traded company, PMI must balance shareholder interests while ensuring sustainable growth. The company is gradually transitioning away from the cigarette business, but abruptly discontinuing a successful product line would be unrealistic and detrimental to long-term success.

 

 

Executive Response: Reducing Demand is Key


 

PMI's Chief Communications Officer, Dr. Moira Gilchrist, emphasized in a video that simply halting cigarette sales will not eliminate market demand.

 

PMI Responds to 'Why is PMI Still Selling Cigarettes': Stopping Sales Is Not the Solution, Driving Consumer Transformation Is Key
PMI Chief Communications Officer Dr. Moira Gilchrist

 

"Philip Morris International unilaterally stopping to sell cigarettes tomorrow won't change a thing. Our transformation makes sense because what we're working on is reducing the demand for cigarettes over the long term," Dr. Moira Gilchrist said.

 

Dr. Moira Gilchrist emphasized that the key action is to gradually reduce cigarette demand over the long term, rather than abruptly halting production. She noted that when she joined PMI in 2006, the company's revenue was entirely derived from cigarette sales. Since then, PMI has gradually reduced its reliance on cigarettes and has been actively promoting the development of smoke-free products.

 

"Fast forward to now and all people need to do is look at the published data. Many people have been somewhat surprised by our transformation and the pace of change."

 

PMI U.S. to Invest About USD 50 Million in New Business Solutions Center in Tampa
PMI U.S. to Invest About USD 50 Million in New Business Solutions Center in Tampa
On March 17, PMI U.S. announced an investment of about USD 50 million in a new Business Solutions Center in Tampa, Florida. The center is expected to create about 180 direct and indirect high-skilled jobs and will consolidate business solutions, distribution operations and customer service into one hub.
Mar.18 by 2FIRSTS.ai
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
U.S.-based medical startup Qnovia Inc. reported positive results from its first-in-human clinical trial of RespiRx, an inhalable nicotine replacement therapy (NRT) device designed to support smoking cessation.
Innovation
Feb.24
Austria to Tighten Sales Rules for Nicotine Pouches and E-Liquids From April 1
Austria to Tighten Sales Rules for Nicotine Pouches and E-Liquids From April 1
Austria will introduce new sales rules for nicotine products from April 1, 2026. Under a reform of the tobacco law passed in December 2025, nicotine pouches will in future be sold only through tobacco shops, while e-liquids will be sold only through tobacco shops and licensed specialist stores. Other points of sale will no longer be permitted to sell these products.
Mar.30 by 2FIRSTS.ai
HB 5437 “Vape Safety Act” advances in House committee, proposing statewide licensing for vape shops
HB 5437 “Vape Safety Act” advances in House committee, proposing statewide licensing for vape shops
A committee substitute for House Bill 5437, the Vape Safety Act sponsored by Del. David McCormick (David McCormick), was recommended Monday afternoon by the House Health and Human Resources Committee to the full House, with the bill next heading to the House Judiciary Committee. HB 5437 would require specialty shops selling tobacco, tobacco-derived products, alternative nicotine, or vapor products and accessories to obtain a state license from the Alcohol Beverage Control Administration (ABCA)
Feb.26 by 2FIRSTS.ai
Myanmar announces ban on e-cigarettes, covering imports/exports, sales, possession and use
Myanmar announces ban on e-cigarettes, covering imports/exports, sales, possession and use
Myanmar’s Ministry of Health said it has received cabinet authorization to enforce an e-cigarette ban under the Essential Supplies and Services Law, listing prohibited acts including the import, export, sale, possession, storage, carrying, distribution and use of vaping products.
Feb.26 by 2FIRSTS.ai
UK vape retailer VPZ to expand manufacturing, open 40 stores in 2026
UK vape retailer VPZ to expand manufacturing, open 40 stores in 2026
UK specialist vape retailer VPZ has launched a multi-million-pound investment programme to boost domestic production capacity and tighten supply-chain controls. The plan includes adding a fifth production line, opening 40 new stores across the UK in 2026 and creating hundreds of jobs, while establishing a bonded warehouse at its Edinburgh headquarters as regulation tightens and a vaping tax is planned.
Feb.02 by 2FIRSTS.ai